Search
Zuellig Pharma

AMGEN BIOTECHNOLOGY SINGAPORE PTE LTD

Featured products of Amgen
Amgevita
Amgevita soln for inj (pre-filled autoinjector) 40 mg/0.8 mL
adalimumab
Packing/Price
2's4's6's1's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
ATC Classification
L04AB04 - adalimumab : Belongs to the class of tumor necrosis factor alpha (TNF-alpha) inhibitors. Used as immunosuppressants.
Amgevita soln for inj (pre-filled syringe) 20 mg/0.4 mL
adalimumab
Packing/Price
1's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
ATC Classification
L04AB04 - adalimumab : Belongs to the class of tumor necrosis factor alpha (TNF-alpha) inhibitors. Used as immunosuppressants.
Amgevita soln for inj (pre-filled syringe) 40 mg/0.8 mL
adalimumab
Packing/Price
6's1's2's4's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
ATC Classification
L04AB04 - adalimumab : Belongs to the class of tumor necrosis factor alpha (TNF-alpha) inhibitors. Used as immunosuppressants.
Blincyto
Blincyto powd for infusion 35 mcg
blinatumomab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FX07 - blinatumomab : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.
Evenity
Evenity soln for inj 105 mg/1.17 mL
romosozumab
Packing/Price
2 × 1's
MIMS Class
Agents Affecting Bone Metabolism
ATC Classification
M05BX06 - romosozumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.
Kanjinti
Kanjinti powd for inj 150 mg
trastuzumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.
Kanjinti powd for inj 440 mg
trastuzumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.
Kyprolis
Kyprolis powd for soln for infusion 30 mg
carfilzomib
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XG02 - carfilzomib : Belongs to the class of proteasome inhibitors. Used in the treatment of cancer.
Mvasi
Mvasi conc for soln for infusion 25 mg/mL
bevacizumab
Packing/Price
4 mL x 1's16 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors. Used in the treatment of cancer.
/singapore/image/info/mvasi conc for soln for infusion 25 mg-ml/25 mg-ml x 4 ml?id=33fae7c4-b199-4069-91cf-ae4e006e83e0
/singapore/image/info/mvasi conc for soln for infusion 25 mg-ml/25 mg-ml x 16 ml?id=4587e241-8b3d-43f6-b6c1-ae4e006e83e1
Neulastim
Neulastim soln for inj 6 mg/0.6 mL
pegfilgrastim
Packing/Price
0.6 mL x 1's
MIMS Class
Haematopoietic Agents, Supportive Care Therapy
ATC Classification
L03AA13 - pegfilgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.
Neupogen
Neupogen soln for inj 30 Million unit/0.5 mL
filgrastim
Packing/Price
0.5 mL x 1's
MIMS Class
Haematopoietic Agents, Supportive Care Therapy
ATC Classification
L03AA02 - filgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.
Parsabiv
Parsabiv soln for inj 2.5 mg/0.5 mL
etelcalcetide hydrochloride
Packing/Price
10 × 1's
MIMS Class
Other Agents Affecting Metabolism
ATC Classification
H05BX04 - etelcalcetide : Belongs to the class of other anti-parathyroid agents. Used in the management of calcium homeostasis.
Parsabiv soln for inj 5 mg/mL
etelcalcetide hydrochloride
Packing/Price
10 × 1's
MIMS Class
Other Agents Affecting Metabolism
ATC Classification
H05BX04 - etelcalcetide : Belongs to the class of other anti-parathyroid agents. Used in the management of calcium homeostasis.
Prolia
Prolia soln for inj 60 mg/mL
denosumab
Packing/Price
1's
MIMS Class
Agents Affecting Bone Metabolism
ATC Classification
M05BX04 - denosumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.
Repatha
Repatha soln for inj 140 mg/mL
evolocumab
Packing/Price
(autoinjector) 1's1's
MIMS Class
Dyslipidaemic Agents
ATC Classification
C10AX13 - evolocumab : Belongs to the class of other lipid modifying agents.
Vectibix
Vectibix conc for soln for infusion 100 mg/5 mL
panitumumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FE02 - panitumumab : Belongs to the class of EGFR (Epidermal Growth Factor Receptor) inhibitors. Used in the treatment of cancer.
Xgeva
Xgeva soln for inj 120 mg/1.7 mL
denosumab
Packing/Price
1's
MIMS Class
Agents Affecting Bone Metabolism
ATC Classification
M05BX04 - denosumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.
Distributed by Zuellig Pharma
Amgevita
Amgevita soln for inj (pre-filled autoinjector) 40 mg/0.8 mL
adalimumab
Packing/Price
2's4's6's1's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
ATC Classification
L04AB04 - adalimumab : Belongs to the class of tumor necrosis factor alpha (TNF-alpha) inhibitors. Used as immunosuppressants.
Amgevita soln for inj (pre-filled syringe) 20 mg/0.4 mL
adalimumab
Packing/Price
1's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
ATC Classification
L04AB04 - adalimumab : Belongs to the class of tumor necrosis factor alpha (TNF-alpha) inhibitors. Used as immunosuppressants.
Amgevita soln for inj (pre-filled syringe) 40 mg/0.8 mL
adalimumab
Packing/Price
6's1's2's4's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
ATC Classification
L04AB04 - adalimumab : Belongs to the class of tumor necrosis factor alpha (TNF-alpha) inhibitors. Used as immunosuppressants.
Blincyto
Blincyto powd for infusion 35 mcg
blinatumomab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FX07 - blinatumomab : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.
Evenity
Evenity soln for inj 105 mg/1.17 mL
romosozumab
Packing/Price
2 × 1's
MIMS Class
Agents Affecting Bone Metabolism
ATC Classification
M05BX06 - romosozumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.
Kanjinti
Kanjinti powd for inj 150 mg
trastuzumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.
Kanjinti powd for inj 440 mg
trastuzumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.
Kyprolis
Kyprolis powd for soln for infusion 30 mg
carfilzomib
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XG02 - carfilzomib : Belongs to the class of proteasome inhibitors. Used in the treatment of cancer.
Mvasi
Mvasi conc for soln for infusion 25 mg/mL
bevacizumab
Packing/Price
4 mL x 1's16 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors. Used in the treatment of cancer.
/singapore/image/info/mvasi conc for soln for infusion 25 mg-ml/25 mg-ml x 4 ml?id=33fae7c4-b199-4069-91cf-ae4e006e83e0
/singapore/image/info/mvasi conc for soln for infusion 25 mg-ml/25 mg-ml x 16 ml?id=4587e241-8b3d-43f6-b6c1-ae4e006e83e1
Neulastim
Neulastim soln for inj 6 mg/0.6 mL
pegfilgrastim
Packing/Price
0.6 mL x 1's
MIMS Class
Haematopoietic Agents, Supportive Care Therapy
ATC Classification
L03AA13 - pegfilgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.
Neupogen
Neupogen soln for inj 30 Million unit/0.5 mL
filgrastim
Packing/Price
0.5 mL x 1's
MIMS Class
Haematopoietic Agents, Supportive Care Therapy
ATC Classification
L03AA02 - filgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.
Parsabiv
Parsabiv soln for inj 2.5 mg/0.5 mL
etelcalcetide hydrochloride
Packing/Price
10 × 1's
MIMS Class
Other Agents Affecting Metabolism
ATC Classification
H05BX04 - etelcalcetide : Belongs to the class of other anti-parathyroid agents. Used in the management of calcium homeostasis.
Parsabiv soln for inj 5 mg/mL
etelcalcetide hydrochloride
Packing/Price
10 × 1's
MIMS Class
Other Agents Affecting Metabolism
ATC Classification
H05BX04 - etelcalcetide : Belongs to the class of other anti-parathyroid agents. Used in the management of calcium homeostasis.
Prolia
Prolia soln for inj 60 mg/mL
denosumab
Packing/Price
1's
MIMS Class
Agents Affecting Bone Metabolism
ATC Classification
M05BX04 - denosumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.
Repatha
Repatha soln for inj 140 mg/mL
evolocumab
Packing/Price
(autoinjector) 1's1's
MIMS Class
Dyslipidaemic Agents
ATC Classification
C10AX13 - evolocumab : Belongs to the class of other lipid modifying agents.
Vectibix
Vectibix conc for soln for infusion 100 mg/5 mL
panitumumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FE02 - panitumumab : Belongs to the class of EGFR (Epidermal Growth Factor Receptor) inhibitors. Used in the treatment of cancer.
Xgeva
Xgeva soln for inj 120 mg/1.7 mL
denosumab
Packing/Price
1's
MIMS Class
Agents Affecting Bone Metabolism
ATC Classification
M05BX04 - denosumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.

Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Already a member? Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Already a member? Sign in